- Presentations
- 3
- Markets
- 1
Romvimza is a brand of Vimseltinib marketed by Deciphera Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Vimseltinib
- Brand owner
- Deciphera Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 14 mg capsule, 20 mg capsule, 30 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Romvimza 14 mg capsuleOral | Deciphera Pharmaceuticals | US FDA | Available on request |
| Romvimza 20 mg capsuleOral | Deciphera Pharmaceuticals | US FDA | Available on request |
| Romvimza 30 mg capsuleOral | Deciphera Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Romvimza
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.